Brad Friedman

Share

Ph.D., Senior Principal Scientist, Department of OMNI Bioinformatics, Genentech, Inc

Read more Interesting and Inspiring Articles

A Cancer Drug for ALS? Organization Forges Promising ALS Treatment, an Innovative Approach to Incubate Novel Therapeutics

Case Study: Consortium Explores KPT-350 as a Potential Treatment for ALS

Target ALS and AFTD Announce $5MM in Grants for Research Targeting Treatments and Biomarkers

Join Us

Keep up with the latest news, events and ways to get involved.